Introduction
============

Tuberculosis (TB) is still a leading cause of illness and death, not only in developing country but also in industrialized settings. The 4-drugs standard regimen is pivotal in TB treatment and is associated with a rapid reduction in infectivity. During the '60s, it was first demonstrated that segregation in sanatoria did not reduce TB transmission among family close contacts of patients. Actually, the incidence of active tuberculosis and tuberculosis infection was shown to be similar among contacts of patients treated at home or treated in sanatorium.[@b1-mjhid-5-1-e2013071],[@b2-mjhid-5-1-e2013071] On the other hand, hospitalization of TB patients has led, in past years, to nosocomial epidemics (often due to multidrug resistant strains) involving healthcare workers and HIV-infected subjects.[@b3-mjhid-5-1-e2013071]--[@b7-mjhid-5-1-e2013071] More recently, ongoing multi-drug resistant TB transmission within Latvian hospitals was demonstrated combining molecular and epidemiological methods (whilst no epidemiological link was found among clustered drug-susceptible TB cases).[@b8-mjhid-5-1-e2013071] Basing on these evidences, domiciliary treatment is considered safe and appropriate in the vast majority of cases. Nonetheless, the infectivity is unlikely to disappear immediately after therapy is started and hospitalization with strict isolation measures during the early phase of treatment remains a common practice in some high-income settings, where isolation areas and controlled ventilation systems are available. Whether this approach can further reduce the risk of disease dissemination in countries with low TB prevalence merits to be investigated further. The use of molecular epidemiology can be extremely useful in this respect, given its ability to identify unapparent pathway of transmission and to define clusters of patients epidemiologically linked.[@b9-mjhid-5-1-e2013071]

Patients and Methods
====================

Study population
----------------

All culture-confirmed cases of tuberculosis observed between 1995 and 1999 in the metropolitan area of Milan with an available Restriction Fragment Length Polymorphism (RFLP) IS6110 analysis were considered in the study. The study was conducted in the urban and suburban area of Milan, comprising an area of more than 5,000,000 inhabitants.

Demographics, clinical characteristics and epidemiological data were obtained from "Istituto Villa Marelli", Milan (the regional reference centre for mycobacterial infection, collecting all strains isolated in the metropolitan area of Milan). Clinical data were integrated with those of patients hospitalized with a diagnosis of tuberculosis at "L.Sacco Hospital" (reference hospital for infectious diseases in Milan). Data were then cross-checked and further integrated with the electronic regional register for infectious diseases notification of Lombardia.

Patients were categorized according to the clinical management during the early phase of treatment, distinguishing two groups: those who were hospitalized before or soon after the diagnosis and those who received domiciliary treatment since the diagnosis.

Molecular epidemiology methods
------------------------------

RFLP genotyping was performed in the mycobacterial laboratory of the Infectious Diseases Clinic of Sacco Hospital, Milan. Extraction of DNA from mycobacterial strains and DNA fingerprinting with IS6110 as a probe were performed as follows: after harvesting and killing of mycobacteria previously cultured on a Lowenstein-Jensen medium, 5 μg of genomic DNA was digested with PvuII. DNA fragments were separated by electrophoresis on agarose gels, denatured, and blotted onto nylon membrane by Southern Blotting. Hybridization was performed overnight at 42°C on PvuII-restricted genomic DNA with a chemiluminescence-labeled 521-bp IS6110 fragment and pgrs on IndiIII-restricted genomic DNA. Presence of DNA probe was assessed with ECL detection system (Amersham), and dendrogram of similarity were obtained comparing RFLP fingerprint with Bionumerics software (Applied Maths, Sint-Martens-Latem, Belgium).

A group of two or more *M. tuberculosis* strains, isolated from different patients, with a RFLP pattern similarity of 100% was considered as a cluster, thus epidemiologically meaning a recent transmission (not necessarily direct). Other RFLP fingerprints were considered ungrouped and classified as sporadic cases. Cluster composed by low-copy-number strains, i.e. strains with a number of IS6110 copies ≤5, were further studied using 12-loci mycobacterial interspersed repetitive units (MIRU) analysis, as described elsewhere,[@b10-mjhid-5-1-e2013071],[@b11-mjhid-5-1-e2013071] in order to confirm or exclude the clustering. Clusters involving more than 5 patients were defined as "macroclusters".

Statistical analysis
--------------------

Uni- and multivariable logistic regression analyses were performed to assess factors associated with clustering. The following factors were tested: age, gender, country of birth, hospitalization at diagnosis, site of infection (pulmonary *versus* extrapulmonary or disseminated), sputum smear examination, case definition (new *versus* relapse/failure), year of diagnosis, drug-resistance, HIV co-infection. A separate category was created for any missing data. All variables associated with the outcome with a P \<0.20 at univariate analysis and hospitalization at diagnosis were included in the multivariable analysis.

Sensitivity analyses were conducted excluding three large clusters, related to nosocomial epidemics among HIV-co infected subjects, and excluding MDR-TB, to ensure that these patient populations were not overtly influencing the results.

The analysis was carried out using SAS/STAT statistic software v8.2 (SAS Institute Inc., Cary, USA) and all P-values presented are two-sided. A P-value \<0.05 indicated conventional statistical significance.

Results
=======

Patients characteristics and clustering
---------------------------------------

Between January 1^st^ 1995 and December 31^st^ 1999, 1139 cases of culture-confirmed TB were reported in the metropolitan area of Milan and had an available clinical isolate for genotypic RFLP analysis. Their characteristics are shown in [Table 1](#t1-mjhid-5-1-e2013071){ref-type="table"}. Among enrolled patients, 392 (34.4%) had been hospitalized before or soon after diagnosis and 405 (35.6%) had received domiciliary treatment since the diagnosis. In 392 (30%) cases, the information about initial clinical management could not be retrieved.

At RFLP analysis, 363 (31.9%) isolates were involved in 115 clusters, whereas 776 (68.1%) isolates had a sporadic pattern. The rate of genetic diversity was therefore 0.78 (891 different patterns among 1139 patients). The dimension of the clusters ranged from 2 to 13 subjects and 104 patients (9.1%) belonged to 13 macroclusters.

Impact of hospitalization
-------------------------

The majority of clusters (76/115 = 66.1%) involved at least one hospitalized patient and 26/115 (22.6%) were composed only by hospitalized patients. The proportion of patients hospitalized at diagnosis remained stable over time, ranging from 35.9% in 1995 to 36.4% in 1999 (Chi-square for trend P=0.744), whilst the proportion of patients involved in clusters decreased from 46.4% in 1995 to 26.4% in 1999 (Chi square for trend P\<0.001).

Using univariate logistic regression analysis, hospitalization was not significantly associated with clustering (OR 1.23, 95%CI 0.91--1.67, p=0.368). Conversely, Italian patients, HIV co-infected subjects and those diagnosed with TB in earlier years were running a significantly higher risk of clustering (see [Table 2](#t2-mjhid-5-1-e2013071){ref-type="table"}).

Using multivariable analysis, hospitalized patients were confirmed not to run a higher risk of clustering than patients who received domiciliary treatment since the diagnosis (OR 1.06, 95%CI 0.75--1.50, p=0.575), independently of other possible confounders. Conversely, HIV co-infection (OR 1.88, 95%CI 1.20--2.95, p=0.006) and MDR TB (OR 2.50, 95%CI 1.46--4.25, p=0.001) were significantly associated with risk of clustering. Moreover, subjects aged \>65 years old (OR 0.60; 95CI% 0.37--0.95; p=0.016) and non-Italian born patients (OR 0.56; 95%CI 0.41--0.76; p\<0.001) were less likely to be involved in clusters.

Sensitivity analysis
--------------------

A sensitivity analysis was carried out excluding three large clusters (25 patients), which were related to nosocomial epidemics of multi-drug resistant TB occurred in the hospitals of Milan city area between 1993 and 1997 and mainly involving Italian HIV-co infected subjects.

After the exclusion of these patients, hospitalization was not significantly associated with clustering (unadjusted OR 1.14, 95%CI 0.84--1.55, p=0.887). Using multivariable analysis, hospitalization was confirmed not to be significantly associated with clustering (OR 1.07, 95%CI 0.76--1.52, p=0.772), independently of age, nationality, year of diagnosis, TB drug susceptibility and HIV-co infection.

Similar results were obtained in a sensitivity analysis performed only on 1059 patients with drug-susceptible TB (data not shown).

Discussion
==========

Since the introduction of effective chemotherapy, domiciliary treatment was demonstrated to be as effective as hospital treatment. A large randomized controlled trial conducted in Madras (presently known as Chennai, India) demonstrated that domiciliary treatment was not associated with an increased risk of transmission to the household contacts of patients suffering from TB, as compared with a 1-year segregation in sanatorium.[@b1-mjhid-5-1-e2013071],[@b2-mjhid-5-1-e2013071] The study, however, was conducted in a setting of high prevalence of TB, as suggested by the very low proportion (30%) of household contacts with negative tuberculin skin testing at baseline and by the high rate (\>20%) of skin test conversion before discharge from sanatorium of the index case.[@b1-mjhid-5-1-e2013071] Moreover, the treatment used in the study was far from being as effective as today, given the high proportion of patients with positive sputum cultures after 1 year of treatment and the high rate of relapse in 5 years.[@b2-mjhid-5-1-e2013071] Therefore, the findings of this study are not immediately generalizable to the present situation of many high-income countries. Subsequent studies conducted in high-income settings during the 70's demonstrated that a policy of early hospital discharge was not associated with TB transmission, thus suggesting that patients can safely be discharged after 2 weeks of treatment, even if sputum smear examination is still positive.[@b12-mjhid-5-1-e2013071]--[@b14-mjhid-5-1-e2013071] However, the comparison of the classic Madras study between institutional and domiciliary treatment since the diagnosis has never been repeated in countries with low TB prevalence, where strict respiratory isolation of patients (single rooms, controlled ventilation system with negative pressure) during the first days of therapy is possible.

In our cohort, all the analyses consistently demonstrated that domiciliary treatment was not associated with TB clustering. Short-course hospitalization was not associated with any advantage in terms of reduced TB clustering. This finding was confirmed even when factors known to influence TB transmission, such as HIV co-infection [@b15-mjhid-5-1-e2013071],[@b16-mjhid-5-1-e2013071] and being local-born [@b15-mjhid-5-1-e2013071],[@b17-mjhid-5-1-e2013071]--[@b20-mjhid-5-1-e2013071], were taken into account. Moreover, a substantial number of the identified clusters of transmission were mainly or completely composed by hospitalized patients, thus suggesting that nosocomial TB transmission could be an issue. Taken all together, our findings support the indication to limit hospitalization to patient for whom there is a clinical indication to hospital treatment, such as patient conditions, the risk of low adherence, the likelihood of infection with multidrug-resistant organism or cohabitation with subjects with high-risk of TB disease (i.e., children \<4 years old).

A high rate of clustering was, however, demonstrated and about one third of patients were shown to be involved in clusters. This finding is consistent with the hypothesis that active transmission is a common phenomenon also in countries with low TB prevalence, as previously reported.[@b21-mjhid-5-1-e2013071],[@b22-mjhid-5-1-e2013071] Much of the transmission is likely to have occurred in the period preceding the diagnosis, when the patients were unaware of any infectiousness, or to have been caused by patients with low adherence to prescribed treatment. Prevention of TB transmission should be therefore focused on these two issues. Human and economical resources should be devoted to early diagnosis and prompt treatment of new TB cases and to active tracing of patients missing scheduled visits.

Despite current national and international guidelines support out-patient management, a significative proportion of the patients in our cohort was admitted to hospital. This finding confirms the results from a previous national survey, demonstrating that the majority of TB patients in Italy are hospitalized.[@b23-mjhid-5-1-e2013071] An excess in hospitalization is likely to lead to unnecessary costs for the Health National System and to a possible higher risk of nosocomial transmission. Therefore, a change in this policy is advisable, because routine hospitalization of all patients with pulmonary TB is still practiced in many points of care. Updates of hospital guidelines and educational programmes addressed to health staff dealing with TB are constantly needed.

The present study has some limitations that should be acknowledged. First, no information was collected on standard epidemiological surveillance (namely, on the rate of tuberculin skin test conversion among contacts). This may have led to underestimate the risk of TB transmission, because most infections are followed by a variable latency period. However, molecular clustering can reasonably approximate epidemiologic clustering and recent transmission in low-incidence populations.[@b9-mjhid-5-1-e2013071] Moreover, since most immunocompetent individuals infected with *M. tuberculosis* remain disease-free during the course of their lives, focusing the study only on active cases of TB can be more informative about the effect of public health policy on the TB epidemic. Second, given the non-randomized, observational nature of the study, we cannot exclude that patients receiving domiciliary treatment were those judged to be less infectious. Nonetheless, the results of our study were confirmed even adjusting for the measurable markers of infectiousness (such as sputum smear positivity).

In any case, a strength of the present study is the large number of the patient involved, which allowed to detect clusters that, in a narrower study, could have resulted to be smaller or even unnoticed. In addition, to our knowledge this is the first time that molecular epidemiology is used to evaluate the impact of the isolation policy on the risk of TB transmission. Such a novel approach could be applied in other settings, in order to evaluate the effect of changes in health care policy on *M. tuberculosis* circulation.

Conclusion
==========

Our results suggest that hospitalization of TB patients is not associated with a reduction in clustering risk. Expanding domiciliary treatment upon diagnosis is an advisable measure to reduce unnecessary costs for the health care system.
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###### 

Patients' characteristics (study population *versus* general population).

  Characteristics                     Study population N=1139
  ----------------------------------- -------------------------
  Age \[ Mean (SD) \]\*               45 (19.9)
                                      
  Female gender \[ N (%) \]           425 (37.4)
                                      
  Country of Birth                    
   Italy                              773 (67.9)
   Other                              366 (32.1)
    North Africa                      39 (3.4)
    Sub-Saharian Africa               55 (4.8)
    South America                     108 (9.5)
    Asia                              50 (4.4)
    Eastern Europe                    17 (1.5)
    Other                             3 (0.3)
    Unknown not-Italian               94 (8.2)
                                      
  Year of diagnosis                   
   1995                               153 (13.4)
   1996                               258 (22.6)
   1997                               160 (14)
   1998                               307 (26.9)
   1999                               261 (22.9)
                                      
  Clinical management \[ N (%) \]     
   Hospitalization                    392 (34.4)
   Domiciliary treatment              405 (35.6)
   Unknown                            342 (30)
                                      
  Case definition \[ N (%) \]         
   New                                969 (85.1)
   Failure/relapse                    26 (2.3)
   Unknown                            144 (12.6)
                                      
  Site of infection \[ N (%) \]       
   Pulmonary                          695 (61)
   Extrapulmonary                     138 (12.1)
   Pulmonary & extrapulmonary         32 (2.8)
   Unknown                            274 (24.1)
                                      
  AFB smear\*\* \[ N (%) \]           
   Positive                           332 (45.7)
   Negative                           147 (20.2)
   Unknown                            248 (34.1)
                                      
  Multi drug resistance \[ N (%) \]   73 (6.4)
                                      
  HIV-Ab positivity \[ N (%) \]       119 (10.4)

AFB, acid-fast bacilli; HIV-Ab, Human Immunodeficiency Virus Antibody; SD, standard deviation; N, number. Age at diagnosis available for 670 patients among the study population and for 768 patients among the general population. Sputum smear microscopic examination for acid-fast bacilli available for 727 patients with pulmonary involvement among the study population and for 821 patients with pulmonary involvment among the general population.

###### 

Risk of clustering. Uni- and multivariable logistic regression analyses

                          Univariable   Multivariable                                        
  ----------------------- ------------- --------------- --------- ------------- ------------ ---------
  Age                                                                                        
   \< 65 years old        1             \-                        1             \-           
   \>65 years old         0.62          0.40--0.94      0.018     0.60          0.37--0.95   0.016
   Unknown                1.01          0.78--1.32      0.083     1.08          0.69--1.67   0.133
                                                                                             
  Female gender           0.80          0.62--1.04      0.102                   Dropped      
                                                                                             
  Non-Italian born        0.62          0.47--0.82      0.001     0.56          0.41--0.76   \<0.001
                                                                                             
  Pulmonary involvement                                           Not entered                
   No                     1             \-                                                   
   Yes                    1.22          0.81--1.83      0.830                                
   Unknown                1.40          0.89--2.19      0.150                                
                                                                                             
  Case classification                                             Not entered                
   New Case               1             \-                                                   
   Relapse or Failure     1.59          0.72--3.50      0.265                                
   Unknown                1.02          0.70--1.48      0.425                                
                                                                                             
  AFB smear                                                       Not entered                
   Negative               1             \-                                                   
   Positive               1.08          0.71--1.64      0.733                                
   Unknown                1.04          0.67--1.62      0.992                                
                                                                                             
  Hospitalization                                                                            
   No                     1             \-                        1                          
   Yes                    1.23          0.91--1.67      0.368     1.06          0.75--1.50   0.575
   Unknown                1.20          0.88--1.64      0.577     0.91          0.59--1.41   0.583
                                                                                             
  Multi drug resistance   3.55          2.18--5.78      \<0.001   2.50          1.46--4.25   0.001
                                                                                             
  HIV-Ab positivity       2.50          1.70--3.67      \<0.001   1.88          1.20--2.95   0.006
                                                                                             
  Year of diagnosis                                                                          
   1999                   1             \-                        1             \-           
   1995                   2.41          1.58--3.67      \<0.001   1.75          1.12--2.73   0.034
   1996                   1.25          0.85--1.83      0.365     1.13          0.76--1.67   0.370
   1997                   1.81          1.18--2.75      0.069     1.76          1.15--2.71   0.022
   1998                   0.98          0.67--1.43      0.003     0.93          0.63--1.36   0.012

AFB, acid-fast bacilli; CI, confidence interval; HIV-Ab, Human Immunodeficiency Virus Antibody; OR, odds ratio. Odds ratios in multivariable model are adjusted for the other variable in the model. Association between clustering and sputum smear microscopic examination for acid-fast bacilli assessed only for patients with pulmonary involvement (N=727)
